USPTO Patent Granted for Keratin Fiber Composition
Summary
The USPTO has granted a patent (US12582596B2) to KAO CORPORATION for a solid cosmetic composition for keratin fibers. The patent details specific formulations involving non-silicone lipophilic compounds, pulverulent excipients, and cationic compounds, with defined concentration limits for excipients and water content.
What changed
The United States Patent and Trademark Office (USPTO) has granted patent US12582596B2 to KAO CORPORATION for a solid cosmetic composition intended for keratin fibers, specifically human hair. The patent outlines a formulation comprising non-silicone lipophilic compounds with a melting point above 25° C, pulverulent excipients (at 1% by weight or more), and cationic/cationizable compounds. Key restrictions include a total water content of less than 10% by weight.
This patent grant is primarily an intellectual property matter and does not impose new regulatory obligations on companies. However, it signifies a specific innovation in cosmetic formulations that may impact market competition and product development within the cosmetics and personal care sector. Companies operating in this space should be aware of this granted patent as it pertains to their product development and intellectual property strategies.
Source document (simplified)
Solid composition for keratin fibers
Grant US12582596B2 Kind: B2 Mar 24, 2026
Assignee
KAO CORPORATION
Inventors
Petra Lobmueller, Andreas Picker, Anja Aechtner
Abstract
The present invention is directed to a solid cosmetic composition for keratin fibers, preferably human keratin fibers, more preferably human hair, comprising: one or more non-silicone lipophilic compound(s) having a melting point above 25° C. under atmospheric pressure, one or more pulverulent excipient(s), one or more cationic and/or cationizable compound(s), wherein the concentration of pulverulent excipients is 1% by weight or more, calculated to the total weight of the composition, and wherein the total concentration of water is less than 10% by weight, preferably less than 5% by weight, more preferably less than 1% by weight, still more preferably less than 0.5% by weight, calculated to the total weight of the composition.
CPC Classifications
A61K 2800/31 A61K 8/922 A61K 8/0216 A61K 8/33 A61K 8/342 A61K 8/37 A61K 8/463 A61K 8/731 A61K 8/19 A61K 8/416 A61K 8/92 A61K 8/0241 A61Q 5/12
Filing Date
2021-12-07
Application No.
17643055
Claims
13
Named provisions
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: Patent Grants - Pharma (A61K) publishes new changes.